CD79b is a B-cell-specific antigen that is crucial to the B-cell receptor and is considered a key target for treatment in aggressive B-cell lymphomas. While immunohistochemical studies have shown widespread expression of CD79b in mature B-cell-derived lymphomas, flow cytometry allows for precise measurement and differentiation between surface and intracellular localization. In our comparative analysis, we discovered that CD79b expression percentages and mean fluorescence intensity (MFI) were lower in a group of 127 cases of aggressive B-cell lymphomas compared to a control group of benign reactive hyperplasia.
View Article and Find Full Text PDFIntroduction: A range of signs and symptoms that often impair up-per extremity function characterizes Multiple Sclerosis (MS). People with MS may have impairments that make some activities of daily living difficult and reduce functional independence. A multidisciplinary rehabilitation approach, combined with pharmacological treatment, can be helpful in improving hand and upper limb function in people with Multiple Sclerosis.
View Article and Find Full Text PDFImage-guided core needle biopsies (IG-CNB) represent a minimally invasive approach for obtaining tissue in patients with lymphadenopathy and suspected lymphoma. Despite their utility, diagnostic challenges persist, with lower efficacy compared with excisional biopsies. Our study aimed to evaluate the potential utility of incorporation of flow cytometry (FC) alongside immunohistochemistry (IHC) when performing IG-CNB for suspected lymphoproliferative diseases.
View Article and Find Full Text PDF